Dawn Parsell Otto

Sr VP, Clinical Development, Tricida.

Companies

  • TricidaSr VP, Clinical Development Aug 8, 2018 to Mar 2, 20221

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Dec 31, 2021Shares withheld for tax 1,574 shares at $9.56 of Tricida2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2